Emergence Agitation

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Humanwell Pharmaceutical
1 program
1
Rematazolam BesylatePhase 41 trial
Active Trials
NCT05624424UnknownEst. Oct 2023

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
Humanwell PharmaceuticalRematazolam Besylate

Clinical Trials (1)

Effect of Rematazolam Besylate, Propofol, and Sevoflurane Perioperative Sedation on Incidence of Emergence Agitation and Hemodynamics in Patients Undergoing Laparoscopic Abdominal Surgery

Start: Nov 2022Est. completion: Oct 2023
Phase 4Unknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space